A new target for differentiation therapy in AML

Peilin Ma, Weihua Song, Jay L. Hess

Research output: Contribution to journalArticle

4 Scopus citations


Despite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.

Original languageEnglish (US)
Pages (from-to)9-10
Number of pages2
JournalCell Research
Issue number1
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'A new target for differentiation therapy in AML'. Together they form a unique fingerprint.

  • Cite this